Those complexes, which are present in blood and tissues from patients suffering from systemic sclerosis (SSc), are DNA-size-dependent and activate plasmacytoid dendritic cells in a TLR9-dependent but CXCR3-independent manner. Here, TLR9 is linked to systemic sclerosis.